文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

穿孔素是自然杀伤细胞控制肿瘤转移的主要因素。

Perforin is a major contributor to NK cell control of tumor metastasis.

作者信息

Smyth M J, Thia K Y, Cretney E, Kelly J M, Snook M B, Forbes C A, Scalzo A A

机构信息

Cellular Immunity Laboratory, Austin Research Institute, Heidelberg, Victoria, Australia.

出版信息

J Immunol. 1999 Jun 1;162(11):6658-62.


DOI:
PMID:10352283
Abstract

We provide the first demonstration, using experimental and spontaneous models of metastasis in C57BL/6 (B6) (RM-1 prostate carcinoma) and BALB/c (DA3 mammary carcinoma) mice, that tumor metastasis is primarily controlled by perforin-dependent cytotoxicity mediated by NK1.1+ cells. MHC class Ilow RM-1 and DA3 tumor cells were sensitive in vitro to Fas-mediated lysis or spleen NK cells in a perforin-dependent fashion. Perforin-deficient NK cells did not lyse these tumors, and perforin-deficient mice were 10-100-fold less proficient than wild-type mice in rejecting the metastasis of tumor cells to the lung. Fas ligand mutant gld mice displayed uncompromised protection against tumor metastasis. Depletion of NK subsets resulted in greater numbers of metastases than observed in perforin-deficient mice, suggesting that perforin-independent effector functions of NK cells may also contribute to protection from tumor metastasis.

摘要

我们利用C57BL/6(B6)(RM-1前列腺癌)和BALB/c(DA3乳腺癌)小鼠的转移实验模型和自发模型首次证明,肿瘤转移主要由NK1.1+细胞介导的穿孔素依赖性细胞毒性控制。MHC II低表达的RM-1和DA3肿瘤细胞在体外对Fas介导的裂解或脾NK细胞以穿孔素依赖性方式敏感。穿孔素缺陷的NK细胞不能裂解这些肿瘤,穿孔素缺陷的小鼠在排斥肿瘤细胞向肺转移方面比野生型小鼠效率低10至100倍。Fas配体突变的gld小鼠对肿瘤转移具有未受损的保护作用。NK亚群的耗竭导致转移灶数量比穿孔素缺陷小鼠中观察到的更多,这表明NK细胞的穿孔素非依赖性效应功能也可能有助于预防肿瘤转移。

相似文献

[1]
Perforin is a major contributor to NK cell control of tumor metastasis.

J Immunol. 1999-6-1

[2]
The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.

J Immunol. 1999-1-15

[3]
Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.

J Immunol. 1999-6-15

[4]
Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.

J Immunol. 1998-10-15

[5]
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.

Cell Immunol. 2001-12-15

[6]
Perforin dependence of natural killer cell-mediated tumor control in vivo.

Eur J Immunol. 1995-12

[7]
Regulation of perforin-independent NK cell-mediated cytotoxicity.

Eur J Immunol. 2003-10

[8]
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.

J Immunol. 1999-7-15

[9]
In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

Cancer Gene Ther. 2004-3

[10]
Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).

J Immunol. 1999-10-15

引用本文的文献

[1]
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.

J Exp Clin Cancer Res. 2025-8-23

[2]
Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma.

Sci Rep. 2025-8-11

[3]
IRF4 expression by NK precursors predetermines exhaustion of NK cells during tumor metastasis.

Nat Immunol. 2025-6-16

[4]
Breaking boundaries: role of the brain barriers in metastatic process.

Fluids Barriers CNS. 2025-1-8

[5]
Immunocytes interact directly with cancer cells in the tumor microenvironment: one coin with two sides and future perspectives.

Front Immunol. 2024

[6]
Metastatic organotropism: a brief overview.

Front Oncol. 2024-4-25

[7]
Granzymes in health and diseases: the good, the bad and the ugly.

Front Immunol. 2024-4-5

[8]
Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance.

Dis Model Mech. 2024-3-1

[9]
Feeder-free differentiation of human iPSCs into natural killer cells with cytotoxic potential against malignant brain rhabdoid tumor cells.

Bioact Mater. 2024-3-8

[10]
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease.

Nat Cancer. 2024-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索